These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 2150026)
1. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study]. Andreozzi GM; Lepore R Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026 [TBL] [Abstract][Full Text] [Related]
2. [Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study]. Minerva Med; 1985 Oct; 76(39):1803-11. PubMed ID: 4047463 [TBL] [Abstract][Full Text] [Related]
3. Buflomedil in arterial occlusive disease: results of a controlled multicenter study. Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127 [TBL] [Abstract][Full Text] [Related]
4. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy]. Paoletti V; Mammarella A; Alessandrini A; Barlattani M Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843 [No Abstract] [Full Text] [Related]
5. [Buflomedil in arterial occlusive disease. Results of a controlled study]. Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854 [No Abstract] [Full Text] [Related]
6. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs]. Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536 [No Abstract] [Full Text] [Related]
7. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs]. Coglitore S; Manganaro A; Barbera MC; Cento D; Buda D; Arrigo F; Consolo F Minerva Cardioangiol; 1986 Nov; 34(11):745-9. PubMed ID: 2949163 [No Abstract] [Full Text] [Related]
8. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs]. Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756 [TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication. Van den Brande P; Maurel A Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510 [TBL] [Abstract][Full Text] [Related]
10. [Effects of buflomedil on peripheral arteriopathies. An open clinical study]. Longo FN; Potortì F; Urbano O; Perroni GB Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229 [No Abstract] [Full Text] [Related]
11. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients. Forconi S; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Ralli L; Guerrini M; Di Perri T J Int Med Res; 1984; 12(3):188-92. PubMed ID: 6734922 [No Abstract] [Full Text] [Related]
12. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs]. Warembourg G; Carre A; Ginestet A; Lambert M Lille Med; 1976 Dec; 21 Suppl 4():898-901. PubMed ID: 1018614 [No Abstract] [Full Text] [Related]
13. [Therapeutic effect of a combination of bufenine and beta-escine as an oral delayed-action drug in obliterating arterial diseases of the lower limbs]. Petruzzellis V; Scardigno A; Coviello C Minerva Med; 1982 Feb; 73(5):181-6. PubMed ID: 7038552 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication]. Diehm C; Eckstein M; Hübsch-Müller C Vasa; 1989; 18(1):40-7. PubMed ID: 2648691 [TBL] [Abstract][Full Text] [Related]
15. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution]. Visconti W; Grillo N Minerva Med; 1985 May; 76(19-20):945-53. PubMed ID: 3158842 [TBL] [Abstract][Full Text] [Related]
17. [Buflomedil chlorhydrate in peripheral vasculopathies]. Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055 [No Abstract] [Full Text] [Related]
18. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study]. Trübestein G; Trübestein R; Ludwig M Fortschr Med; 1989 Dec; 107(36):781-4. PubMed ID: 2695437 [TBL] [Abstract][Full Text] [Related]
19. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation. Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530 [TBL] [Abstract][Full Text] [Related]
20. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil]. Dorigo B; Raspanti D; Trapani M; Albanese B; Cameli AM; Digiesi V Minerva Med; 1985 Feb; 76(7):269-75. PubMed ID: 3974940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]